Protamine enhances uptake of cationic liposomes in angiogenic microvessels of solid tumours

[1] Denekamp J., Review article: Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy, Br J Radiol, 66, pp. 181-196, (1993)

[2] Eichhorn M.E., Strieth S., Dellian M., Anti-vascular tumor therapy: Recent advances, pitfalls and clinical perspectives, Drug Resist Updat, 7, pp. 125-138, (2004)

[3] Kerbel R.S., Tumor angiogenesis: Past, present and the near future, Carcinogenesis, 21, pp. 505-515, (2000)

[4] Los M., Voest E.E., The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer, Semin Oncol, 28, pp. 93-105, (2001)

[5] Bloemendal H.J., Logtenberg T., Voest E.E., New strategies in antivascular cancer therapy, Eur J Clin Invest, 29, pp. 802-809, (1999)

[6] Olson T.A., Mohanraj D., Roy S., Ramakrishnan S., Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate, Int J Cancer, 73, pp. 865-870, (1997)

[7] Thurston G., McLean J.W., Rizen M., Et al., Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice, J Clin Invest, 101, pp. 1401-1413, (1998)

[8] Krasnici S., Werner A., Eichhorn M.E., Et al., Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels, Int J Cancer, 105, pp. 561-567, (2003)

[9] Campbell R.B., Fukumura D., Brown E.B., Et al., Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors, Cancer Res, 62, pp. 6831-6836, (2002)

[10] Augustin H.G., Braun K., Telemenakis I., Et al., Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression, Am J Pathol, 147, pp. 339-351, (1995)

[1] Denekamp J., Review article: Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy, Br J Radiol, 66, pp. 181-196, (1993)

[2] Eichhorn M.E., Strieth S., Dellian M., Anti-vascular tumor therapy: Recent advances, pitfalls and clinical perspectives, Drug Resist Updat, 7, pp. 125-138, (2004)

[3] Kerbel R.S., Tumor angiogenesis: Past, present and the near future, Carcinogenesis, 21, pp. 505-515, (2000)

[4] Los M., Voest E.E., The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer, Semin Oncol, 28, pp. 93-105, (2001)

[5] Bloemendal H.J., Logtenberg T., Voest E.E., New strategies in antivascular cancer therapy, Eur J Clin Invest, 29, pp. 802-809, (1999)

[6] Olson T.A., Mohanraj D., Roy S., Ramakrishnan S., Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate, Int J Cancer, 73, pp. 865-870, (1997)

[7] Thurston G., McLean J.W., Rizen M., Et al., Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice, J Clin Invest, 101, pp. 1401-1413, (1998)

[8] Krasnici S., Werner A., Eichhorn M.E., Et al., Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels, Int J Cancer, 105, pp. 561-567, (2003)

[9] Campbell R.B., Fukumura D., Brown E.B., Et al., Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors, Cancer Res, 62, pp. 6831-6836, (2002)

[10] Augustin H.G., Braun K., Telemenakis I., Et al., Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression, Am J Pathol, 147, pp. 339-351, (1995)